Correction to: Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States
Yiling Jiang
◽
Eric M. Sarpong
◽
Pamela Sears
◽
Engels N. Obi
2020 ◽
Vol 23
◽
pp. S144-S145
Y. Jiang
◽
E.N. Obi
◽
P.S. Sears
◽
E. Sarpong
Yiling Jiang
◽
Eric M. Sarpong
◽
Pamela Sears
◽
Engels N. Obi
2012 ◽
Vol 15
(4)
◽
pp. A212
J. Xie
◽
M. Diener
◽
G. De
◽
E.Q. Wu
◽
M. Namjoshi
2018 ◽
Vol 21
(8)
◽
pp. 770-777
◽
Ryan Clark
◽
Duygu Bozkaya
◽
Mark Levenberg
◽
Steven Faulkner
◽
Timothy W. Smith
◽
...
2020 ◽
Vol 23
◽
pp. S16-S17
V. Ektare
◽
R. Liu
◽
J. Stephens
◽
A. Al Taie
◽
A. Shelbaya
S.A. Foster
◽
S. Milev
◽
M. Hoog
◽
O. Mason
◽
A. Sardesai
◽
...
J. Jandu
◽
F. Naylor
◽
E. McAughey
◽
A. Samiian
◽
M. Blackney
◽
...
2010 ◽
Vol 13
(8)
◽
pp. 893-902
◽
Erika G. Martin
◽
A. David Paltiel
◽
Rochelle P. Walensky
◽
Bruce R. Schackman
2021 ◽
Vol 24
◽
pp. S234-S235
J. Nesheim
◽
J.V. Chen
◽
J.C. Gahn
◽
P. Mudd
2012 ◽
Vol 15
(4)
◽
pp. A238
X.Y. Huang
◽
T. Lodise
◽
D. Friedland
◽
E.J. Beresford